Cabergoline
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Cabergoline and local guidelines before prescribing.
Mechanism
Long-acting dopamine D2 agonist reducing prolactin secretion.
Uses
Hyperprolactinaemia and prolactinoma, acromegaly adjunct, suppression of lactation.
Dosing
- Cabergoline (preferred): Usually 250–500 micrograms once or twice weekly, titrated to normalise prolactin. In most patients it normalises prolactin, shrinks the tumour (often within weeks) and restores vision and fertility.
Endocrinology: Pituitary Disease - Cabergoline Prolactinoma | Typically 250–500 micrograms once or twice weekly, titrated monthly to normalise prolactin. Warn about impulse control disorders; echo surveillance at higher cumulative doses.
Endocrinology: Pituitary Disease
Side effects
Nausea, dizziness, headache, postural hypotension; psychiatric effects including impulse-control disorders; valvular fibrosis at high doses.
Interactions
Dopamine antagonists (antipsychotics, metoclopramide) oppose effect.
Contraindications and cautions
History of fibrotic disorders, cardiac valvulopathy
Monitoring
Prolactin, echocardiogram on long-term high dose
Pregnancy and breastfeeding
Stop at conception in most cases
Renal and hepatic impairment
Caution in severe liver disease
Overdose and reversal
Supportive; hypotension
Special advice
Echocardiography for long-term or high-dose use; monitor prolactin and tumour size.
More from the textbook: uses, cautions and other points
- Serotonergic drugs: Historically pergolide, cabergoline and fenfluramine.
Cardiology: Valvular heart disease › 4.29 Carcinoid Heart Disease - Ergot derivatives (cabergoline, bromocriptine) | Pleural and pulmonary fibrosis
Respiratory: Anatomy, Physiology and Pharmacology - Cabergoline | Prolactinoma first-line; impulse control disorders; valve fibrosis at high doses.
Endocrine: Anatomy Physiology and Pharmacology - Compulsive gambling after starting a prolactinoma drug | Cabergoline impulse control disorder
Endocrine: Anatomy Physiology and Pharmacology - 💡 Clinical Pearl: Unlike other pituitary tumours, a macroprolactinoma compressing the chiasm is treated first with medicine (cabergoline), not surgery. Vision often improves within days.
Endocrinology: Pituitary Disease - Cabergoline - for mild disease.
Endocrinology: Pituitary Disease
Where it is discussed in the book
- Cardiology: Valvular heart disease (1 mention)
- Respiratory: Anatomy, Physiology and Pharmacology (1 mention)
- Endocrine: Anatomy Physiology and Pharmacology (2 mentions)
- Endocrinology: Pituitary Disease (7 mentions)
- Endocrinology: Adrenal Disease (1 mention)
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Neurology: Movement Disorders (1 mention)
- Obstetrics (3 mentions)
- Obstetrics: Complications (3 mentions)
- Gynaecology: Fertility Contraception Menopause (2 mentions)
- Integrated cardiology chapter (1 mention)